Exelixis Inc (EXEL)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 10.01B
P/E Ratio
17.88
Revenue (TTM)
$ 2.23B
Volume
0
52W High
$ 49.62
52W Low
$ 25.12
Dividend Yield
0.00%
Beta
0.29
Technicals
50-Day MA
41.1582
200-Day MA
37.971
52 Week High
49.62
52 Week Low
25.12
About EXEL
Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
Employees
1147
Headquarters
Alameda, CA
CEO
Dr. Stelios Papadopoulos Ph.D.